ROYAL BANK OF CANADA - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 109 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$5,000
-28.6%
8,0000.0%0.00%
Q3 2019$7,0000.0%8,000
-25.2%
0.00%
Q2 2019$7,000
-46.2%
10,700
-31.8%
0.00%
Q1 2019$13,000
-13.3%
15,700
+71.6%
0.00%
Q4 2018$15,000
-55.9%
9,150
-11.6%
0.00%
Q3 2018$34,000
+88.9%
10,352
+29.4%
0.00%
Q2 2018$18,0008,002
+3220.3%
0.00%
Q3 2015$02410.0%0.00%
Q2 2015$0
-100.0%
241
-98.9%
0.00%
Q3 2013$45,000
-48.9%
22,204
-36.6%
0.00%
Q2 2013$88,00035,0000.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,866,483$4,285,0002.24%
Sarissa Capital Management LP 2,570,759$3,843,0001.32%
Greylock XI GP Limited Partnership 584,004$876,0000.56%
Deer VI & Co. LLC 675,242$1,013,0000.44%
DAFNA Capital Management LLC 261,507$391,0000.34%
Palo Alto Investors LP 2,858,348$4,274,0000.18%
Baupost Group 3,829,350$5,725,0000.14%
SABBY MANAGEMENT, LLC 573,416$857,0000.05%
Granahan Investment Management 676,451$1,011,0000.03%
TFS CAPITAL LLC 176,633$264,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders